Sun, X., Zhen, X., Hu, X., Li, Y., Gu, S., Gu, Y., . . . Dong, H. (2021). Cost-utility analysis of imrecoxib compared with diclofenac for patients with osteoarthritis. Cost Eff Resour Alloc.
Citação norma ChicagoSun, Xueshan, Xuemei Zhen, Xiaoqian Hu, Yuanyuan Li, ShuYan Gu, Yuxuan Gu, Zixuan Zhao, Wei Yang, and Hengjin Dong. "Cost-utility Analysis of Imrecoxib Compared With Diclofenac for Patients With Osteoarthritis." Cost Eff Resour Alloc 2021.
MLA CitationSun, Xueshan, et al. "Cost-utility Analysis of Imrecoxib Compared With Diclofenac for Patients With Osteoarthritis." Cost Eff Resour Alloc 2021.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.